Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | ZNRF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ZRANB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |